{
 "drug": "Imipenem and Cilastatin Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "01/08/2026",
 "dayN": 229,
 "cat": "Anti-Infective",
 "companies": [
  "Merck Sharp & Dohme Corp."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "01/08/2026",
   "update_type": "New",
   "initial_posting_date": "01/08/2026",
   "package_ndc": "0006-3516-59",
   "generic_name": "Imipenem and Cilastatin Injection",
   "contact_info": "800-672-6372",
   "related_info": "To be discontinued in approximately Q4 2026.",
   "openfda": {
    "application_number": [
     "NDA050587"
    ],
    "brand_name": [
     "PRIMAXIN IV"
    ],
    "generic_name": [
     "IMIPENEM AND CILASTATIN SODIUM"
    ],
    "manufacturer_name": [
     "Merck Sharp & Dohme LLC"
    ],
    "product_ndc": [
     "0006-3516",
     "0006-3514",
     "0006-3551",
     "0006-3552"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "IMIPENEM",
     "CILASTATIN SODIUM"
    ],
    "rxcui": [
     "1726204",
     "1726207",
     "1726214",
     "1726216"
    ],
    "spl_id": [
     "34854f9b-7be0-4bfb-8cd2-40baf206fb80"
    ],
    "spl_set_id": [
     "f41d8abd-7792-4918-1b93-bd83ea01955e"
    ],
    "package_ndc": [
     "0006-3514-58",
     "0006-3516-59",
     "0006-3551-58",
     "0006-3552-59"
    ],
    "unii": [
     "71OTZ9ZE0A",
     "5428WXZ74M"
    ]
   },
   "update_date": "01/08/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Primaxin, Injection, 500mg (NDC 0006-3516-59)",
   "company_name": "Merck Sharp & Dohme Corp.",
   "status": "To Be Discontinued"
  }
 ]
}